← All stocks

CLOVER HEALTH INVESTMENTS, CORP. /DE

CLOV Net selling

CIK 0001801170 #1978 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$1.67M

$1.57M on a plan · $0.00 straight out of an exercise

Sold at will

$103.20K

1 of 5 sales

Net

−$1.67M

−$103.20K against sales at will

By person

16 insiders · 5 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Wai Conrad

CEO, Counterpart Health

—

$1.42M (1) scheduled

−$1.42M

3,625,811

0.692%

$17.11M

−17.9%

OLDAKOWSKI JOSEPH FRANK

VP OF FINANCE AND CONTROLLER

—

$103.20K (1)

−$103.20K

279,067

0.053%

$1.32M

−10.3%

THORNTON JOSEPH CLAY

Interim CFO

—

$78.03K (1) scheduled

−$78.03K

1,249,526

0.238%

$5.90M

+0.9%

Reynoso Jamie L.

CEO, Medicare Advantage

—

$44.32K (1) scheduled

−$44.32K

2,805,367

0.535%

$13.24M

+9.0%

Soares Karen

Chief Legal Officer

—

$32.72K (1) scheduled

−$32.72K

1,607,371

0.307%

$7.59M

+21.2%

Toy Andrew

Chief Executive Officer

—

9,459,316

1.8%

$44.65M

−6.4%

Kuipers Peter J.

Chief Financial Officer

—

5,758,353

1.1%

$27.18M

−15.9%

Priest Brady Patrick

CEO of Clover Care Services

—

2,040,222

0.389%

$9.63M

−3.5%

Garipalli Vivek

Director

—

1,856,247

0.354%

$8.76M

+31.7%

Kouzoukas Demetrios L.

Director

—

605,980

0.116%

$2.86M

+30.1%

Clinton Chelsea

Director

—

602,814

0.115%

$2.85M

+11.3%

SHAPIRO LEE

Director

—

598,622

0.114%

$2.83M

+11.3%

Robinson William G Jr

Director

—

597,987

0.114%

$2.82M

+30.7%

Loengard Anna U

Director

—

557,066

0.106%

$2.63M

+42.8%

Edwards Carladenise Armbrister

Director

—

285,432

0.054%

$1.35M

−30.8%

Tran Thomas L

Director

—

180,029

0.034%

$849.74K

+353.6%

Individual transactions

Insider

Date

Role

Action

Price

Amount

OLDAKOWSKI JOSEPH FRANK

14 Sep 2026

VP OF FINANCE AND CONTROLLER

Sell

20,000

$5.16

$103.20K

Show all 5 transactions →

What was left out

Form 4 filings counted 5

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 4

Sales straight out of an exercise 0

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 0

History held since 11 Jan 2021